Health policy experts said it is still unclear how much prices will go down, which medicines will be impacted and whether the effort can be implemented at all.

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the pharmaceutical industry before he’s even signed an executive order he says will lower

President Donald Trump on Monday revived a plan to tie prescription drug prices in the U.S. to what other nations pay for medicines. The executive order, which was first reported by POLITICO, still leaves many questions about how the administration will implement a so-called “most-favored nation” policy.